Clinical Pharmacokinetic Study of Lurbinectedin in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Impairment

NCT05101265 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor
Hepatic Impairment

Interventions

DRUG: Lurbinectedin
DRUG: Lurbinectedin

Sponsor

PharmaMar